The new, full-range TECNIS Odyssey intraocular lens aims to reduce dependence on glasses, with strong performance in any ...
The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence., Bizz ...
Medical Device Network on MSN
FDA approves J&J’s TECNIS PureSee intraocular lens
The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.
Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...
The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
Johnson & Johnson (JNJ) wins FDA approval for Tecnis PureSee intraocular lens ((IOL)), giving eye surgeons a new lens option ...
Johnson & Johnson introduces the TECNIS Odyssey IOL in India, enhancing vision for cataract patients with advanced technology.
TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S ...
My New York City practice has been a refractive-only practice for more than 25 years, offering the full range of FDA-approved ...
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for ...
Enhancement coverage applies within 24 months of the original procedure for refractive and premium lens pathways. Beyond this ...
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results